Evidence map›Paper›PMID 35133630›Full record

Trial reportAdvances in therapy2022

A Feasibility Study: Testing Whether a Sleep Application Providing Objective Sleep Data to Physicians Improves Patient-Physician Communication Regarding Sleep Experiences, Habits, and Behaviors.

Sana Durrani, Sha Cao, Na Bo, Jennifer K Pai, Jarod Baker, Lori Rawlings, Zaina P Qureshi, Ninotchka L Sigua, Shalini Manchanda, Babar Khan

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Advances in therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Sana DurraniRegenstrief Institute, 1101 West 10th Street, Indianapolis, IN, 46202, USA.
Sha CaoIndiana University, 1050 Wishard Blvd., Indianapolis, IN, 46202, USA.
Na BoIndiana University, 1050 Wishard Blvd., Indianapolis, IN, 46202, USA.
Jennifer K PaiMerck & Co., Inc., Boston, MA, USA.
Jarod BakerRegenstrief Institute, 1101 West 10th Street, Indianapolis, IN, 46202, USA.
Lori RawlingsRegenstrief Institute, 1101 West 10th Street, Indianapolis, IN, 46202, USA.
Zaina P QureshiMerck & Co., Inc., Kenilworth, NJ, USA.
Ninotchka L SiguaDivision of Pulmonary, Critical Care, Sleep and Occupational Medicine, Department of Medicine, Indiana University School of Medicine, 535 Barnhill Drive, Indianapolis, IN, 46202, USA.
Shalini ManchandaDivision of Pulmonary, Critical Care, Sleep and Occupational Medicine, Department of Medicine, Indiana University School of Medicine, 535 Barnhill Drive, Indianapolis, IN, 46202, USA.
Babar KhanRegenstrief Institute, 1101 West 10th Street, Indianapolis, IN, 46202, USA. bakhan@iu.edu.
Indiana University – Purdue University Indianapolis · USRegenstrief Institute · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USIndiana University School of MedicineSidney & Lois Eskenazi Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSleep tracker data have not been utilized routinely in sleep-related disorders and their management. Sleep-related disorders are common in primary care practice and incorporating sleep tracker data may help in improving patient care. We conducted a pilot study to assess the feasibility of a sleep program using the Fitbit Charge 2™ device and SleepLife

methodsA prospective, randomized, parallel group, observational pilot study was conducted in 20 primary care clinics in Indianapolis, IN from June 2018 to February 2019. Inclusion criteria included patients over the age of 18, have a diagnosis of insomnia identified by electronic medical record and/or a validated questionnaire, and were on a prescription sleep aid. The study was not specific to any sleep aid prescription, branded or generic, and was not designed to evaluate a drug or drug class. Each primary care clinic was randomized to either the SleepLife

resultsForty-nine physicians and 75 patients were enrolled in the study. Patients had a mean age of 57 (SD 12.8) years and 61% were female. Mean age of physicians was 47 (SD 10.6) years. Patients showed high rates of involvement in the program with 83% completing all survey questions. Physician survey completion rate was 55%. Only one physician logged into the SleepLife portal to check their patients' sleep status. At the end of the 6-week intervention, patients' composite general satisfaction scores with sleep health management decreased significantly in the intervention arm when compared to controls (p = 0.03). Patients' satisfaction with communication also decreased significantly in the intervention group (p = 0.01). The sleep outcomes, which were calculated on the basis of study questionnaire answers, improved significantly in the intervention group as compared to the control group (p = 0.04). Physician communication satisfaction scores remained unchanged (p = 0.12).

conclusionsSleepLife

Indexed as

PhysiciansSleep Wake DisordersAdultCommunicationFeasibility StudiesFemaleHabitsHumansMiddle AgedPilot ProjectsProspective StudiesSleepCommunicationPrimary careSleepSmartphone appTechnologyTracker

Identifiers

PMID35133630
PMCPMC8989828
OpenAlexW4210936702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.